期刊文献+

抗抑郁药治疗社交焦虑障碍的临床研究 被引量:1

Clinical study of antidepressants in the treatment of social anxiety disorder
暂未订购
导出
摘要 社交焦虑障碍(SAD)是一种常见的、能导致社会功能受损的疾病,是继重度抑郁发作、酒精依赖后的第三大常见精神障碍。患者社交功能、职业功能和日常生活等均可因此受到严重影响。本文就近年抗抑郁药治疗SAD的研究进展进行综述。 Social anxiety disorder (SAD) is a common disease, which can lead to impaired social function. It is the third most common mental disorders. Social function, professional features and aspects of daily life of patients can be affected seriously. This article reviews the development of antidepressants in the treatment of social anxiety disorder in recent years.
作者 何磊英 陆峥
出处 《世界临床药物》 CAS 2009年第7期431-436,共6页 World Clinical Drug
关键词 社交焦虑障碍 选择性5-羟色胺再摄取抑制剂 可逆性单胺氧化酶抑制剂 5-羟色胺和去甲肾上腺素再摄取抑 制剂 social anxiety disorder selective serotonin reuptake inhibitors reversible monoamine oxidase inhibitors serotonin-norepinephrine reuptake inhibitors.
  • 相关文献

参考文献3

  • 1陆峥,张明园,蔡军,施慎逊,吴文源,季建林,张海音,刘义兰,周天骍,陈银娣,陈圣祺,赵宝龙,瞿正万,何燕玲.帕罗西汀治疗社交焦虑症的多中心开放性临床验证[J].中华精神科杂志,2002,35(2):115-118. 被引量:35
  • 2Murray B. Stein,Mark H. Pollack,Alexander Bystritsky,Jeffrey E. Kelsey,Richard M. Mangano. Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial[J] 2005,Psychopharmacology(3):280~288
  • 3Irene M. Vliet,Johan A. Boer,Herman G. M. Westenberg. Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine[J] 1994,Psychopharmacology(1-2):128~134

二级参考文献1

  • 1张明园.副反应量表[J].上海精神医学,1984,2:77-80.

共引文献34

同被引文献16

  • 1Soares CN,Komstein SG,Thase ME,Jiang Q,Guico-Pabia CJ Assessing the efficacy of desvenlefaxine for improving functioning and well -being outcome measures in patients with major depressive disorder:a pooled analysis of 9 double-blind,placebo-controlled,8-week clinical trials.J Clin Psychiatry 2009 Oct; 70 (10):1365-71.
  • 2Pendi-Perumal SR,Srinivasan V,Poeggeler B,Hardeland R,Ccardinali DP.Drugs insight:the use of melatouergic agonists for the treatment of insoumia-focus on rameheon.Nat Clin Praet Neurol.2007,3:221 -228.
  • 3S.Kasper,L.Laigle,F.Bayle.P.2.c.022 Superior entidepressant efficacy of agomelatine versus sertraline:a randemised,double-blind study European Neuropsychopharmacolngy,Volume 18,Issue null,Pages S336-S337.
  • 4(1).Hale A,Corral R,Mencacci O,Seiz Ruiz J,Gentil V.Superior efficacy of ngomelatine vs fluoxetine in severe MDD patients:a randomised,double-blind study.
  • 5Benazzi F,Berk M,Frye MA,Wang W,Barraco A,Tohen M,Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar 1 disorder:a post hoc analysis.J Clin Psychiatry 2009 Oct; 70 (10):1424 -31.
  • 6Thase ME,Diagnosis and treatment of a major depressive episode.[Journal Article] J Clin Psychiatry 2009 Oct; 70 (10):e37.
  • 7Author (s):Rosa N Schnyer,DiplAc,and John J B Allen,PhD,Acupuncture in the Treatment of Depression.A Manual for Practice and Research 2001,Pages 87-132.
  • 8安磊.选择性5-羟色胺再摄取抑制剂安全应用与评价[J].中国医院用药评价与分析,2008,8(4):253-257. 被引量:5
  • 9肖艳,李丽辉,崔玉红,王丽红.抗抑郁药的研究进展及临床应用[J].齐齐哈尔医学院学报,2008,29(11):1363-1367. 被引量:6
  • 10吴丽华,王振宁,黎曙霞,黄伟侨,郑志华,刘宇恒.2004-2007年广东省50家医院抗抑郁药用药分析[J].中国实用医药,2008,3(26):26-28. 被引量:4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部